Peripheral blood and intrahepatic subsets of T lymphocyte activation and function in liver allograft rejection and drug-induced tolerance in rats

Transplant Immunology

Volumn 4, Issue 2, 1996, Pages 126-132

  Davenport, M ^a   Peakman, M ^a   Dunne, J B ^a   Gonde, C E ^a   Vergani, D ^a   Williams, Roger ^a   Tredger, J M ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; LIVER TRANSPLANTATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL; T LYMPHOCYTE ACTIVATION;

EID: 0030174896     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(96)80006-2     Document Type: Article

References (45)

1. Kamada N. Animal models of hepatic allograft rejection. Semin Liver Dis. 12:1992;1-15.
2. Engemann R, Ulrichs K., Theide A, Muller-Ruchholtz W, Hamelmann H. Graft tolerance after orthotopic liver transplantation in a primarily nontolerant strain combination following temporary cyclosporin A treatment. Theide A. Microsurgical models in rats for transplantation research. 1985;247-253 Springer Verlag, Berlin.
3. Murase N, Kim D.-G, Todo S, et al. Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. Transplantation. 50:1990;186-189.
4. Murase N, Kim D.-G, Todo S, Cramer D.V, Fung J, Starzl T.E. FK506 suppression of heart and liver allograft rejection. Transplantation. 50:1990;739-744.
5. Cramer D.V, Chapman F.A, Jaffee B.D, et al. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver and kidney allograft rejection in the rat. Transplantation. 53:1992;303-308.
6. Gassel H.-J, Engemann R, Thiede A, Hamelmann H. Replacement of donor Kupffer cells by recipient cells after orthotopic liver transplantation. Transplant Proc. 19:1987;351-353.
7. Kamada N. The immunology of experimental liver transplantation in the rat. Immunology. 55:1985;369-389.
8. Roser B.J, Kamada N, Zimmermann F, Davies Hff.S. Immunosuppressive effect of experimental liver allografts. Calne R.Y. second edition Liver transplantation. 1987;35-56 Grune & Stratton, London.
9. Kamada N, Davies Hff.S, Roser B.J. Fully allogeneic liver grafting and the induction of donor specific unreactivity. Transplant Proc. 13:1981;837-841.
10. Houssin D, Charpentier B, Gugenheim J, et al. Spontaneous longterm acceptance of RT-1 incompatible liver allografts in inbred rats. Transplantation. 36:1983;615-620.
11. Hutchinson I.V. Suppressor T cells in allogeneic models. Transplantation. 41:1986;547-555.
12. Araujo J.-L, Kupiec-Weglinski J.W, Araneda D, et al. Phenotype activation status, and suppressor activity of host lymphocytes during acute rejection and after cyclosporine-induced unresponsiveness of rat cardiac allografts. Transplantation. 40:1985;278-284.
13. Tsuchimoto S, Kakita A, Uchino J, et al. Mechanism of tolerance in rat liver transplantation: evidence for the existence of suppressor cells. Transplant Proc. 19:1987;514-518.
14. Starzl T.E, Demetris A.J, Trucco M, et al. Systemic chimerism in human female recipients of male livers. Lancet. 340:1992;876-877.
15. Starzl T.E, Demetris A.J, Trucco M, et al. Chimerism and donor specific non-reactivity 27 to 29 years after kidney transplantation. Transplantation. 55:1993;1272-1277.
16. Ellis T.M, Lee H.M, Mohanakumar T. Alterations in human regulatory T lymphocyte subpopulations after renal allografting. J Immunol. 127:1981;2199-2203.
17. Shen S.Y, Weir M.R, Kosenko A, et al. Reevaluation of T cell subset monitoring in cyclosporine-treated renal allograft recipients. Transplantation. 40:1985;620-623.
18. Winkler M, Schwinzer R, Wonigeit K. Patterns of MHC class II antigen expression (HLA-DR, DP, DQ) on peripheral blood T lymphocytes in patients after liver transplant. Transplant Proc. 21:1989;3627-3628.
19. McDiarmid S.V, Cook D.J, Mickey M.R, et al. The development of a lymphocyte population with suppressor phenotype after successful liver transplantation. Transplant Proc. 21:1989;423-424.
20. Herrod H.G, Williams J, Dean P.J. Alterations in immunological measurements in patients experiencing early hepatic allograft rejection. Transplantation. 45:1988;923-925.
21. Eidelmann F.J, Guttman R.D. Serial monitoring of peripheral blood lymphocyte subsets in cardiac allograft rejection in the rat. Transplantation. 47:1989;1079-1081.
22. Sun J, Wu M, Hou T, et al. Induction of unresponsiveness to rat hepatic allografts by pretreatment with donor splenocytes and peritransplant cyclosporine. Transplantation. 50:1990;1070-1072.
23. Zimmermann F.A, Schmid T, Schmid U, et al. Fine-needle aspiration cytology of orthotopic liver allografts in rats. Thiede A. Microsurgical models in rats for transplantation research. 1985;237-242 Springer-Verlag, Berlin.
24. Kubota N, Monden M, Hasuika Y, et al. Lymphocyte infiltration and Ia expression in liver allografts in rats. Transplant Proc. 20:1988;214-216.
25. Knechtle S.J, Wolfe J.A, Burchette, Sanfilippo F, Bollinger R.R. Infiltrating cell phenotypes and patterns associated with hepatic allograft rejection or acceptance. Transplantation. 43:1987;169-172.
26. Ruiz P, Harland R, Yamaguchi Y, Bollinger R.R, Sanfilippo F. In situ and systemic cellular immunity associated with orthotopic rat liver allograft acceptance or rejection. Transplant Proc. 21:1989;416-420.
27. Peakman M, Tredger J.M, Davies E.T, et al. Analysis of peripheral blood mononuclear cells in rodents by 3-colour flow cytometry using a small-volume lysed whole blood technique. J Immunol Methods. 158:1993;87-94.
28. Kamada N, Calne R.Y. A surgical experience with 530 liver transplants in the rat. Surgery. 93:1983;64-69.
29. Tredger J.M, Gonde C.E, Williams R. Monitoring cyclosporine in liver transplant recipients: effects of clinical status on the performance of two monoclonal antibody-based methods. Clin Chem. 38:1992;108-113.
30. Settaf A, Milton A.D, Spencer S.C, et al. Donor class I and class II major histocompatibility complex antigen expression following liver allografting in rejecting and non-rejecting rat strain combinations. Transplantation. 46:1998;32.
31. Hancock W.W, Lord R.H, Colby A.J, et al. Identification of IL2R+ T cells and macrophages within rejecting rat cardiac allografts and comparison of the effects of treatment with anti-IL2R monoclonal antibody or cyclosporin. J Immunol. 138:1987;164-170.
32. c/s markets in the blood ofcyclosporine-treated, allografted rats. Transplantation. 39:1985;624-628.
33. Pearce N.W, Spinelli A, Gurley K.E, Dorsch S.E, Hall B.M. Mechanisms maintaining antibody-induced enhancement of allografts. II. Mediation of specific suppression by short lived CD4+ T cells. J Immunol. 143:1989;499-506.
34. Oluwole S.F, Reemtsma K, Hardy M.A. Characteristics and function of suppressor T lymphocytes in immunologically unresponsive rats following pretreatment with UV-B-irradiated donor leukocytes and peritransplant cyclosporine. Transplantation. 47:1989;1001-1007.
35. Gassel H.-J, Hutchinson I.V, Tellides G, et al. Phenotypic characterisation of T-suppressor lymphocytes induced by orthotopic rat liver transplantation. Transplant Proc. 21:1989;429-430.
36. Gassel H.-J, Hutchinson I.V, Engemann R, Morris P.J. The role of T suppressor cells in the maintenance of spontaneously accepted orthotopic rat liver allografts. Transplantation. 54:1992;1048-1053.
37. Gassel H.-J, Hutchinson I.V, Engemann R, Morris P.J. The role of T suppressor cells in the maintenance of spontaneously accepted orthotopic rat liver allografts. Transplantation. 54:1992;1048-1053.
38. Seki S, Masuda T, Ohteki T, et al. Identification of activated T cell receptor γδ lymphocytes in the liver of tumour-bearing host. J Clin Invest. 86:1990;409-415.
39. Tilney N.L, Kupiec-Weglinski J.W. Biology of acute rejection. Ann Surg. 214:1992;98-106.
40. McCaughan G.W, Davies J.S, Waugh J.A, et al. A quantitative analysis of T lymphocyte populations in human liver allografts undergoing rejection: the use of monoclonal antibodies and double immunolabeling. Hepatology. 12:1990;1305-1313.
41. Richards S.J, Scott C.S. Immunophenotyping dissection of normal peripheral blood NK-associated (NKa) subpopulations by flow cytometry: morphologicalfeatures and relationships between NKa (CD11b, CD16, CD56 and CD57) and T cell (CD2, CD3, TCR, CD5, CD7, CD8 and CD38) associated determinant expression. Leukemia Lymphoma. 2:1990;111-126.
42. Kohda H, Sekiya C, Kanai, et al. Flow cytometric and functional analysis of mononuclear cells infiltrating the liver in experimental autoimmune hepatitis. Clin Exp Immunol. 82:1990;473-478.
43. Quill H, Schwartz R.H. Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative non-responsiveness. J Immunol. 141:1987;2216-2220.
44. Jenkins M.K, Schwartz R.H. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell responsiveness in nitro and in vivo. J Exp Med. 165:1987;3704.
45. Sidhu S, Deacock S, Bal V, Batchelor J.R, Lombardi G, Lechler R.I. Human T cells cannot act as autonomous antigen presenting cells, but induce tolerance in antigen-specific and alloreactive responder cells. J Exp Med. 176:1992;875-880.